Clinical Trial

Application of Changyanning Granule in Endoscopic Resection of Colorectal Polyps

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated April 15, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the efficacy of Chanyanning granules in patients undergoing endoscopic resection of colorectal polyps with a basal diameter of 5-30 mm. From one day before the procedure to five days postoperatively, patients will be administered Chanyanning granules. The study will observe intraoperative and postoperative bleeding, perforation, and digestive system-related clinical symptoms such as postoperative abdominal pain, bloating, diarrhea, constipation, hematochezia, and fatigue, as well as related inflammatory markers, to determine the therapeutic effect of Chanyanning granules.
Protocol Amendment History 1 change
notable Sponsor changed: Second Affiliated Hospital, School of Medicine, Zhejiang University -> Second Affiliated Hospital, Zhejiang University, School of Medicine 2026-08-09
Trial Details
NCT Number NCT06927258
Lead Sponsor Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions Colorectal Polyps
Enrollment 1,000 participants
Start Date 2024-11-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2026-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-15